Thermo Fisher Scientific (TMO) Current Deferred Tax Assets (2009 - 2015)

Thermo Fisher Scientific has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $263.3 million for Q3 2015.

• Quarterly Current Deferred Tax Assets rose 14.18% year-over-year to $263.3 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $263.3 million (up 14.18% YoY) and the FY2014 annual result came in at $303.3 million, up 57.56% from the prior year.
• Current Deferred Tax Assets eased to $263.3 million in Q3 2015, from $283.5 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $303.3 million in Q4 2014 and troughed at $157.8 million in Q4 2011.
• A 5-year average of $212.8 million and a median of $195.2 million in 2011 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2011 — Current Deferred Tax Assets decreased 12.96% — and 2014, when it jumped 57.56%.
• Tracing TMO's Current Deferred Tax Assets over 5 years: stood at $157.8 million in 2011, then gained by 15.34% to $182.0 million in 2012, then rose by 5.77% to $192.5 million in 2013, then surged by 57.56% to $303.3 million in 2014, then slipped by 13.19% to $263.3 million in 2015.
• Business Quant data shows TMO's Current Deferred Tax Assets at $263.3 million in Q3 2015, $283.5 million in Q2 2015, and $299.4 million in Q1 2015.